Nasus Pharma Ltd.
$2.86
▼
-7.84%
2026-04-21 08:29:00
www.nasuspharma.com
ASE: NSRX
Explore Nasus Pharma Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$19.29 M
Current Price
$2.86
52W High / Low
$9.99 / $1.98
Stock P/E
—
Book Value
$0.31
Dividend Yield
—
ROCE
-172.62%
ROE
2637.84%
Face Value
—
EPS
$-0.72
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
7
Beta
—
Debt / Equity
4.26
Current Ratio
2.25
Quick Ratio
2.24
Forward P/E
—
Price / Sales
—
Enterprise Value
$21.6 M
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
$20
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | MIRA Pharmaceuticals, Inc. | $1.12 | — | $47.06 M | — | -100.98% | -1.66% | $2.45 / $0.83 | $0.25 |
| 2. | AstraZeneca PLC | $196.47 | 30 | $305.64 B | 1.58% | 15.97% | 22.84% | $15,730 / $9,651 | $31.38 |
| 3. | Medicus Pharma Ltd. | $0.34 | — | $13.54 M | — | -27863.04% | -29.81% | $8.94 / $0.29 | $-0 |
| 4. | Pfizer Inc. | $26.9 | 19.83 | $152.79 B | 6.25% | 10.17% | 8.89% | $28.75 / $21.87 | $15.21 |
| 5. | Novo Nordisk A/S | $39.12 | 10.82 | $131.02 B | 4.54% | 39.01% | 60.7% | $533.4 / $224.25 | $6.83 |
| 6. | Amgen Inc. | $346.69 | 24.37 | $187.08 B | 2.84% | 13.95% | 1.06% | $391.29 / $261.43 | $16.07 |
| 7. | Scilex Holding Company | $6.95 | — | $58.97 M | — | 55.67% | 39.83% | $34.27 / $3.6 | $-29.75 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -4.9 M | -1.08 M | -1.15 M | -2.04 M |
| Net Profit | -5.86 M | -1.53 M | -1.05 M | -1.71 M |
| EPS in Rs | -0.5 | -0.13 | -0.09 | -0.15 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5 M | 0.72 M | 0.44 M | 0.42 M |
| Total Liabilities | 2.24 M | 3.93 M | 4.24 M | 3.2 M |
| Equity | 2.77 M | -3.21 M | -3.8 M | -2.79 M |
| Current Assets | 4.86 M | 0.46 M | 0.44 M | 0.42 M |
| Current Liabilities | 2.16 M | 3.93 M | 4.24 M | 3.2 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -4.92 M | -0.67 M | -1.03 M | -1.21 M |
| Investing CF | -3.01 M | 0 M | 0 M | -0.16 M |
| Financing CF | 8.92 M | 0.77 M | 1.05 M | 1.24 M |
| Free CF | -4.93 M | -0.67 M | -1.03 M | -1.21 M |
| Capex | -0.01 M | — | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -282.25% | -45.77% | 38.57% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.